Lumida
/TNGX
⌘K
Tango Therapeutics Inc

Tango Therapeutics Inc

TNGX
$23.78USD+1.75%+0.41 today

MARKET CAP

4.0B

P/E (TTM)

FWD P/E

DAY RANGE

$23 – $25

52W RANGE

$6
$34

AI Summary

Stalk
TrimMedium

TNGX is exhibiting Stage 3 distribution characteristics, with price below declining 9 and 20 EMAs and a recent bounce into the 20 EMA that has not been decisively rejected. The medium-term bias remains bearish, favoring sell-side engagement on rallies. Short-term conditions are neutral, suggesting deferred execution until resistance at the 20/9 EMA zone is confirmed. The long-term uptrend above the 200 DMA is intact but would be threatened by a breakdown below the 50 SMA.

  • 92% objective response rate in MTAP-deleted, RAS-mutant pancreatic cancer Phase 1/2 trial
  • $1 billion cash as of June 2026 extends funding into late-stage studies
  • Q2 net loss of $55.3 million (-$0.37/share) with $0 collaboration revenue
Full analysis →

Buying

12

institutions

Selling

6

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
RI

Rtw Investments, LP

Q2 2026

BUY13.90 M434.53 M+600.00 K+56.2%3.71%
BI

Blackrock, Inc.

Q2 2026

BUY12.44 M388.83 M+3.69 M+112.5%0.01%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW12.28 M383.78 M+12.28 M+0.0%1.78%
FC

Farallon Capital Management LLC

Q1 2026

SELL9.10 M190.32 M+-3.96 M+64.5%0.00%
WP

Woodline Partners LP

Q2 2026

SELL4.00 M125.06 M+-12.00 M-62.6%0.39%
PA

Perceptive Advisors LLC

Q2 2026

BUY3.38 M105.57 M+1.76 M+212.2%1.59%
JH

Janus Henderson Group Plc

Q1 2026

BUY4.79 M100.13 M+2.15 M+326.7%0.02%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL2.12 M66.16 M+-1.71 M-17.4%0.08%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.42 M46.32 M+1.35 M+3481.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW748.30 K23.39 M+748.30 K+0.0%0.03%
FA

Fisher Asset Management, LLC

Q2 2026

BUY578.16 K18.07 M+415.76 K+432.0%0.01%
MM

Millennium Management LLC

Q2 2026

BUY496.04 K15.51 M+70.39 K+74.1%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY339.26 K10.61 M+89.34 K+102.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL298.34 K9.33 M+-235.60 K-16.5%0.01%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL252.11 K7.88 M+-187.91 K-14.4%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL91.03 K2.85 M+-16.26 K+26.8%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY76.76 K2.40 M+26.76 K+129.4%0.11%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY36.42 K1.14 M+81.00+49.8%0.00%